4
Changes in Ownership
Climb Bio, Inc. Filed Acc 0001415889-24-019147
EVP, R&D AND CSO sold 50,000 shares at $6.76 ($338,000)
- EVP, R&D AND CSO acquired 7,649 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Morisset Valerie EVP, R&D AND CSO | 2024-07-01 | Option exercise | +7,649 | $0.00 | $2 | 512,956 | D |
| Morisset Valerie EVP, R&D AND CSO | 2024-07-03 | Sale | −50,000 | $6.76 | $338,000 | 462,956 | D |
| Derivatives | |||||||
| Morisset Valerie EVP, R&D AND CSO | 2024-07-01 | Option exercise · Stock Option (Right to Buy) | −7,649 | 10,198 | D | ||
| Open-market sales · 50,000 sh · avg $6.76 · $338,000 | |||||||
Loading xslF345X05/form4-07032024_060700.xml…